Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Huifeng Bio-Pharma Expects 50% Revenue Increase in 2010

publication date: Feb 5, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Huifeng Bio-Pharmaceutical Technology reported it expects 2009 revenues to be between $13 million and $14 million, about 30% better than last year. Net income is forecast to be as much as $3 million. The big news is that Huifeng predicts 2010’s revenues will be in a range between $20 million and $25 million, an increase of 50% or more. More details...

Stock Symbol: (OTCBB: HFGB)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners